Background: Resistance of Acinetobacter baumannii to carbapenems is a rising problem. Colistin and Tigecycline provided a new hope for the treatment of infections caused by carbapenem resistant A. baumannii. Aim of the work: The current study aimed at assessment of Carbapenem resistant Acinetobacter baumannii among its clinical isolates as well as the in vitro activity of Tigecycline and Colistin against ...
إقراء المزيد